title: Reverse-engineering clinical biology. A peacetime dividend yields drug trials on virtual patients.
authors.forename: Gary
authors.initials: G
authors.lastname: Stix
mesh_terms: D003198:Computer Simulation; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010599:Pharmacokinetics; D012984:Software; D013678:Technology, Pharmaceutical
chemical_list: D004364:Pharmaceutical Preparations